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Human T-cell leukemia virus type 1 (HTLV-1) causes adult T-cell leukemia (ATL). The minus
strand of HTLV-1 provirus encodes a bZIP protein donated as HTLV-1 bZIP factor (HBZ).
Among the HTLV-1 regulatory and accessory genes, the tax and HBZ genes were thought
to play critical roles in oncogenesis. However, HBZ is the only gene that remains intact and
is consistently expressed in all ATL cases, while the tax gene is frequently inactivated by
epigenetic modiﬁcations or deletion of the 5′LTR. HBZ gene promotes the proliferation of
ATL cells through its mRNA form. Moreover, HBZ induces T-cell lymphoma and systemic
inﬂammation in vivo. HBZ fulﬁlls its functions mainly through regulating HTLV-1 5′LTR tran-
scription and modulating a variety of cellular signaling pathways which are related with cell
growth, immune response, andT-cell differentiation.Taken together, the multiple functions
of HBZ render its predominant function in leukemogenesis of ATL.
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INTRODUCTION
Human T-cell leukemia virus type 1 (HTLV-1) was the ﬁrst
retrovirus proven to be associated with human disease. The infec-
tion of HTLV-1 causes adult T-cell leukemia (ATL) and chronic
inﬂammatory diseases including HTLV-1-associated myelopathy
(HAM)/tropical spastic paraparesis (TSP; Uchiyama et al., 1977;
Poiesz et al., 1980). HTLV-1 belongs to deltaretrovirus family,
which include HTLV-2, HTLV-3, and HTLV-4; the simian T-
cell lymphotropic viruses (STLV-1, STLV-2, and STLV-3) and the
bovine leukemia virus (BLV; Matsuoka and Jeang, 2007). Like
other retroviruses, the HTLV-1 proviral genome has structural
genes, gag, pol, and env, ﬂanked by long terminal repeat (LTR) at
both ends (Figure 1; Matsuoka and Jeang, 2007). The character-
istic of HTLV-1 proviral genome is the presence of pX region
between env and 3′LTR, and encoded several accessory genes,
which include tax, rex, p12, p21, p30, p13, and HTLV-1 bZIP
factor (HBZ ; Gaudray et al., 2002; Nicot et al., 2005). HBZ was
ﬁrst identiﬁed as an antisense viral protein that associated with
cAMP-response element binding protein-2 (CREB-2) in HTLV-1-
infected cells (Gaudray et al., 2002). We found that the expression
of HBZ is conserved in all ATL cells (Satou et al., 2006), and non-
sense mutations of all HTLV-1 genes except the HBZ gene were
generated byAPOBEC3G before integration of the provirus (Fan
et al., 2010). In addition, the HBZ gene promotes the proliferation
of ATL cells (Satou et al., 2006). Thus, the HBZ gene is believed
to be essential for leukemogenesis. In this review, we discuss the
updated understanding of HTLV-1 and focus on the roles of HBZ
in HTLV-1 oncogenesis.
STRUCTURE OF HBZ
The existence of a viral transcript encoded by the minus strand of
the HTLV-1 provirus was reported in 1989 (Larocca et al., 1989).
Thereafter, a viral protein that binds to CREB-2 was identiﬁed
by yeast 2-hybrid screening system, and termed as HTLV-1 bZIP
factor (HBZ; Gaudray et al., 2002). The 5′RACE experiment iden-
tiﬁed the transcription start sites of HBZ were located in the U3
and R regions of the HTLV-1 3′LTR (Satou et al., 2006). 5′LTR of
HTLV-1 was frequently lost and methylated in ATL cases, while
3′LTR was not deleted and remained unmethylated (Matsuoka
and Jeang, 2007). It may be one of the reasons why HBZ is consis-
tently expressed in all ATL cells. Two transcripts of the HBZ gene
have been revealed: a spliced form (sHBZ) and an unspliced form
(usHBZ ; Figure 1). The promoter of the spliced and unspliced
HBZ transcriptswasTATA-less and contained initiators anddown-
stream promoter elements (Yoshida et al., 2008). Detailed analyses
of the promoter of sHBZ gene showed that Sp1 sites were critical
for its transcription. U3 region of LTR in the both end of HTLV-
1 proviral genome contains Tax-response element (TRE), which
acts as an enhancer of viral transcription. Tax and CREB can acti-
vate transcription of the HBZ gene through 3′LTR, meanwhile,
Tax regulated antisense promoter activity is inﬂuenced by the
integration site. However, Tax induced 3′LTR activation is not as
signiﬁcant as it did on the transcription of the HTLV-1 plus strand
(Landry et al., 2009).
The spliced and unspliced HBZ genes are translated into a
polypeptide of 206 and 209 amino acids, respectively. Both forms
of HBZ contain three domains: N-terminal activation domain
(AD), central domain (CD), and basic ZIP domain (bZIP) in the
C-terminal (Figure 2). There are two LXXLL-like motifs located
within the N-terminal AD domain of HBZ. Both are important
for the binding to p300/CBP (Clerc et al., 2008). The HBZ protein
is localized in the nucleus with a speckled pattern. Three nuclear
localization signals (NLSs)were identiﬁed to two regions in theCD
of HBZ and a basic region of the bZIP domain (Hivin et al., 2005).
Moreover, the integrity of HBZ protein sequence was necessary for
its accumulation in nuclear speckles. HBZ speciﬁcally distributed
in the nucleus to heterochromatin, while it is not associated with
heterochromatin (Hivin et al., 2005).
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FIGURE 1 | Schematic diagram of spliced HBZ, unspliced HBZ andTax.Tax is encoded by the positive strand of HTLV-1 proviral genome. HBZ is located on
the complementary strand and transcribed from 3′LTR. Spliced and unspliced HBZ are showed. Shaded boxes represent their coding regions.
FIGURE 2 | Schematic diagram of HBZ domains. HBZ has three
domains: activation domain (AD), central domain (CD), and basic ZIP
domain (bZIP). Functions of each domain are listed.
The only difference between the protein form of sHBZ and
usHBZ are seven amino acids in their N-terminal, while it
causes signiﬁcant difference between these two proteins. The
half-life of usHBZ protein is much shorter than that of sHBZ
(Yoshida et al., 2008). In ATL cell, only sHBZ protein could be
detected, since sHBZ gene is more predominant than usHBZ gene
(Usui et al., 2008).
TRANSCRIPTION OF THE HBZ GENE
The transcription of HTLV-1 viral gene is the symbol of HTLV-
1 infection. Among all of the HTLV transcripts, the tax gene
is thought to play critical role in leukemogenesis because of its
pleiotropic functions. However, about 60% of ATL cases lost
the tax expression by three mechanisms: (1) deletion of HTLV-1
5′LTR, (2) hypemethylation of 5′LTR, and (3) non-sensemutation,
deletion, and insertion of tax gene (Matsuoka and Jeang, 2007).
Moreover, the loss of Tax is believed to occur during the process
of oncogenesis. It indicates that Tax expression is not always nec-
essary for ATL. Unlike 5′LTR, HTLV-1 3′LTR is intact and remains
unmethylated. The HBZ gene expression was conserved in all
ATL cases. In addition, expression of the HBZ gene could be
detected not only in ATL cells but also in HTLV-1-infected car-
riers, furthermore, its expression are well correlated with proviral
load. It has been reported the correlation between the level of
the HBZ gene and severity of HAM/TSP, indicating that HBZ
might contribute to the development of HAM/TSP except for ATL
(Saito et al., 2009).
The two forms of the HBZ gene are not equally expressed in
ATL cells. The expression level of the sHBZ gene was found to
be four times higher than that of the usHBZ gene transcript in
HTLV-1 carriers and ATL cases.
In PBMCs from HTLV-1-infected rabbits revealed that the tax
genewas expressed at the highest levels immediately after infection
and progressively decreased, eventually stabilizing at low levels.
However,HBZ wasdetectable at low levels early after infection, and
slowly increased and stabilized. At 8 weeks post infection, the HBZ
mRNA was expressed at the highest concentration of all mRNA
measured (an average of ninefold more than tax mRNA; Li et al.,
2009). Additionally, Suemori et al. (2009) reported that the expres-
sion levels of HBZ mRNA and HBZ protein in HTLV-1-infected
cells were not parallel, suggest that the post transcriptional regula-
tion of HBZ gene may differ among different cell types. However,
other group detected the consistently high level of HBZ mRNA
and protein in ATL- and HTLV-1-associated cell lines (Satou et al.,
2006; Zhao et al., 2011). The physiological level of HBZ could
regulate the cellular signaling pathway, which is critical for T-cell
differentiation. The discrepancy between two independent studies
may due to the different experiment condition and different HBZ
antibody they used.
THE BIOLOGICAL FUNCTION OF HBZ
INHIBITION OF TAX-MEDIATED VIRAL TRANSCRIPTION
HBZ was ﬁrstly identiﬁed as a CREB-2 binding protein which
could inhibit HTLV-1 transcription from 5′LTR. Further study
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showed the association between HBZ and CREB (Lemasson
et al., 2007). HBZ bZIP domain is responsible for its interact-
ing with CREB-2/CREB. These interactions abolished the binding
of CREB-2/CREB to the Tax-responsive element (TxRE) in the
HTLV-1 5′LTR and the cyclic AMP-response element (CRE) in
cellular promoters, resulting in the suppression of Tax-mediated
transcription from 5′LTR (Gaudray et al., 2002; Lemasson et al.,
2007). In addition, HBZ interacts with CBP/p300 co-activator and
suppressed the transcription from the 5′LTR by Tax (Clerc et al.,
2008). Through two LXXLL-like motifs in the N-terminal AD,
HBZ binds with CBP/p300 KIX domain, inhibiting the recruit-
ment of CBP/p300 to the HTLV-1 promoter. Further study found
that HBZ-AD interacts with the MLL binding surface of KIX
domain (Cook et al., 2011).
PROLIFERATION OF ATL CELLS
Stable expression of HBZ maintains the growth of Kit 225 cells
(Satou et al., 2006). When knock down the expression of HBZ
in ATL cell lines, MT-1 and TL-Om1, by siRNA, their prolifera-
tion was suppressed (Satou et al., 2006). It indicated that HBZ is
essential for the continuous expansion of ATL cells. Furthermore,
studies of the growth of T-cell lines transfected with the mutated
HBZ genes showed that HBZ promotes T-cell proliferation in its
mRNA form, whereas HBZ suppresses Tax-mediated viral tran-
scription via protein form. Mutation analyses of the HBZ gene
showed that HBZ RNA promotes cell proliferation by forming
secondary stem-loop structures. HBZ RNA activates transcrip-
tion of E2F1 and its target genes, and increases G1/S transition
(Satou et al., 2006).
Spliced HBZ could induce the proliferation of ATL cells, while
usHBZ could not (Yoshida et al., 2008). It suggests that the ﬁrst
exon of the sHBZ transcript is critical for its growth promoting
activity. The ﬁrst exon of HBZ corresponds to the Rex-responsive
element (RxRE) of the HTLV-1 3′LTR. It is known that Rex pro-
motes the export of viral RNA with an RxRE region. Together,
we speculate that sHBZ RNA form stem-loop structure, which
different as usHBZ RNA, inducing the proliferation of ATL cells.
ATF3, an HBZ binding protein, was highly expressed in ATL
cells. ATF3 expression has positive and negative effects on the
proliferation and survival of ATL cells. HBZ impairs its nega-
tive effects, leaving ATF3 to promote proliferation of ATL cells
via mechanisms including upregulation of CDC2 and cyclin
E2. HBZ may take it as advantages to promote the cell survive
(Hagiya et al., 2011).
MODIFICATION OF AP-1 SIGNALING
Previous studies show that the interaction between bZIP proteins
affects their cellular localization and modulates transcriptional
activity. Activator protein-1 (AP-1) functions as a dimer com-
prised of bZIP proteins of Jun family (c-Jun, JunB, JunD), Fos
family (c-Fos, FosB, Fra-1, Fra-2), and others. HBZ interacted
with c-Jun/JunB and repressed c-Jun/JunB mediated signaling by
abrogating its DNA-binding capacity. HBZ induced the degrada-
tion of c-Jun protein through a proteasome-dependent pathway,
while it is in a ubiquitin-independent manner (Basbous et al.,
2003; Matsumoto et al., 2005; Isono et al., 2008). In addition, HBZ
inhibited AP-1 signaling by sequestrating c-Jun in nuclear bodies.
On the contrary, HBZ can activate transcription mediated by
JunD via forming heterodimers with JunD (Thebault et al., 2004).
HBZ/JunD heterodimers interact with Sp1 transcription factors
and enhanced the transcription of telomerase reverse transcrip-
tase (hTERT; Thebault et al., 2004). Since telomerase activation
is thought to be associated with tumor malignant, the induc-
tion of hTERT by HBZ may be implicated in the oncogenesis
of ATL.
SUPPRESSION OF THE CLASSIC NF-κB PATHWAY
In ATL, Tax-mediated nuclear factor-κB (NF-κB) activation plays
an important role in the proliferation of ATL cells and in the trans-
forming activity of HTLV-1 (Yamaoka et al., 1996). Activation of
NF-κB by Tax includes both the classical and alternative pathways.
Contrary, HBZ selectively suppresses the p65 mediated classical
NF-κB pathway without inhibiting alternative NF-κB signaling
(Zhao et al., 2009). There are two mechanisms involved in this
inhibition. Onemechanism is thatHBZ inhibits p65DNA-binding
ability via interacting with p65. Another is that HBZ increases
the expression of PDLIM2, an E3 ubiquitin ligase for p65, lead-
ing to the increase of p65 ubiquitination and degradation (Zhao
et al., 2009). Both activation and bZIP domains are necessary for
the inhibition of classic NF-κB pathway by HBZ. The selective
modulation of classical NF-κB pathway by HBZ might explain
the predominant activation of alternative pathway, and perhaps to
oncogenesis. PDLIM2has been reported to suppress Tax-mediated
tumorigenesis by targeting Tax into nuclear matrix for proteaso-
mal degradation (Yan et al., 2009). Together, this may offer an
explanation for the repression of Tax in ATL cells, by which HBZ
activates the expression of PDLIM2 and PDLIM2 subsequently
functions to degrade Tax. The updated report showed that HBZ
inhibits the acetylation of p65. It may contribute to the repression
of classical NF-κB pathway by HBZ.
Recent studies suggest that the classical NF-κB pathway is
mostly involved in innate immunity and inﬂammatory responses.
The inhibition of NF-κB pathway is common among differ-
ent viruses, suggesting that these activities are important for
viral survival and infection. HTLV-1 might facilitate escape from
the host immune attack by suppressing the classical NF-κB
pathway by HBZ.
INDUCED TREG DIFFERENTIATION THROUGH ENHANCING
TGF-β SIGNALING
Adult T-cell leukemia cells, present a CD4+CD25+ pheno-
type, have the same markers as those of natural regulatory T
cells (Tregs; Matsuoka and Jeang, 2007). Expression of FoxP3
was detected in two-thirds of ATL cases, indicating that ATL
may originates from natural Treg cells infected with HTLV-1
(Karube et al., 2004). Recently, we found that transgenic expres-
sion of HBZ increases Foxp3+ Treg cells and effector/memory
T cells, leading to development of T-cell lymphomas and sys-
temic inﬂammatory diseases (Satou et al., 2011). It is well known
that TGF-β signaling is critical for the development of Treg.
Our study showed that HBZ enhanced TGF-β signaling in a
p300-dependent manner (Zhao et al., 2011). HBZ, Smad3, and
p300 formed a ternary complex, and the association between
Smad3 and p300 was enhanced in the presence of HBZ. HBZ
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could overcome the suppressive effect of Tax on TGF-β path-
way. The enhancement of TGF-β signaling by HBZ leads to
the up-regulation of Foxp3 in naïve T cells (Zhao et al., 2011).
This might account for why HTLV-1 infection increases Tregs in
vivo. Interestingly, HBZ maintains the cell growth even with the
presence of TGF-β, and HBZ does not inﬂuence the expression
of genes associated with cell cycle and proliferation. It indi-
cates HBZ selectively modulates actions of TGF-β/Smad signaling
pathway.
By enhancing TGF-β pathway and Foxp3 expression, HBZ
enables HTLV-1 to convert infected T cells into Tregs, which is
thought to be a critical strategy for virus persistence.
PATHOGENIC FUNCTION OF HBZ
Tax is recognized as an oncoprotein, since it immortalizes primary
T cells and confers proliferative properties to HTLV-1-infected
cells. However, transcript of the tax gene is detected in only 40% of
ATLcases. InTax transgenicmice, cancerswere induceddepending
on the promoter used (Lairmore et al., 2005). To better under-
stand the pathogenic function of HBZ, we generated transgenic
mice expressing HBZ under mouse CD4 promoter and enhancer.
The HBZ transgenic mice (HBZ-Tg) present many similarities
in symptoms and immunological features with HTLV-1-infected
individuals (Satou et al., 2011). In the total splenocytes of HBZ
transgenic mice, the percentage of CD4-positive T cells increased.
In addition, HBZ promotes the proliferation of thymocytes from
transgenic mice. More than one third of HBZ-Tg mice devel-
oped T-cell lymphomas after a long latent period. To study the
underlying molecular mechanisms, we analyzed the phenotype
and function of T cells and found CD4+Foxp3+ Tregs and effec-
tor/memoryCD4+ Tcells increased in vivo. Thehighpercentage of
Foxp3+ cells inHBZ-Tgmice is also observed in lymphoma tissues
from human ATL patients. However, the increased CD4+Foxp3+
Treg cells in HBZ transgenic mice were functionally impaired
since HBZ could physically interact with Foxp3 and NFAT,
thereby impairing the suppressive function of Treg cells (Satou
et al., 2011). In addition, most of HBZ transgenic mice sponta-
neously develop inﬂammatory lesions in the skin and lung, and
CD3+CD4+ T cells inﬁltrated into the dermis and epidermis in
the lesions. These ﬁndings are similar to those observed inHTLV-1
carriers.
IMPAIRED CELL-MEDIATED IMMUNITY
Viruses have strategies to escape the host immune attack and to
replicate in vivo. HTLV-1 infection is complicated by opportunis-
tic infections. However, it was still unknown how HTLV-1 causes
immune deﬁciency. Recently, we found that HBZ transgenic mice
weremore vulnerable to the infections of herpes simplex virus type
2 (HSV-2) and Listeria monocytogenes (LM) than non-Tg mice
(Sugata et al., 2012). The production of Th1 cytokines, such as
IFN-γ, IL-2, and TNF-α, was suppressed in HBZ-Tg mice. More-
over, the impaired production of IFN-γ is also observed in primary
CD4 T cells from ATL patients. This study has shown that HBZ
suppresses the IFN-γpromoter activity through suppressingNFAT
and AP-1 signaling pathways (Sugata et al., 2012). Together, it is
the ﬁrst report shown that HBZ inhibits CD4 T-cell responses,
resulting in impaired host immunity in vivo.
THE RELATIONSHIP BETWEEN TAX AND HBZ
Accumulating evidence showed that Tax and HBZ are two impor-
tant factors for ATL. The crossover and the interaction between
these two proteins are important for the HTLV-1 oncogenesis.
Tax could transform rodent cells and immortalizes human pri-
mary T cells, moreover, it enhances viral replication, supports
cellular proliferation, inhibits apoptosis, impairs cell-cycle check-
points, and induces DNA damages. Although Tax has pleiotropic
functions as mentioned above, ∼60% of all ATL cases did not
express Tax. Moreover, abortive genetic changes, including dele-
tions, insertions, and non-sense mutations, were frequent in all
viral genes include the tax gene. Non-sense mutations in the tax
gene were also observed in proviruses from asymptomatic car-
riers. Contrary to the tax gene, HBZ is consistently expressed
in all ATL cells and remains intact through the whole period
of ATL development. Tax plays a central role in the immortal-
ization of T-lymphocytes in cell culture, on the contrary, HBZ
was dispensable for viral-induced immortalization of primary
human T cells (Arnold et al., 2006). Tax is the major target of
cytotoxic T-lymphocytes (CTLs) in vivo (Kannagi et al., 1991),
while HBZ is not a target antigen for HTLV-1-speciﬁc CTLs
(Suemori et al., 2009). Since HBZ promote the T-cell prolifera-
tion and induced lymphoma and chronic inﬂammation which is
similar to those in HTLV-1-infected individuals, we believe HBZ
play more important role in the maintenance of HTLV-1-induced
transformation.
Interestingly, Tax and HBZ have opposite effect on the reg-
ulation of cellular signaling pathways (Table 1). Tax activates
5′LTR transcription; enhances AP-1 and classic NF-κB signal-
ing, and suppresses TGF-β pathway. Contrary, HBZ suppressed
Tax-mediated HTLV-1 viral transcription; inhibit activated AP-
1 and classical NF-κB signaling. However, HBZ enhances TGF-β
pathway. HTLV-1 may take advantage of this opposite function
of Tax and HBZ on regulating signaling pathway to allowing the
better survive of HTLV-1-infected cells and escape the immune
surveillance.
Table 1 | Character and regulatory function ofTax and HBZ.
Tax HBZ
Expression in ATL cells ∼40% 100%
Contain genetic changes Yes No
Function as mRNA ND Yes
Immortalize T cells Yes No
Target by CTL Yes No
HTLV-1 5′LTR transcription Activate Inhibit
Classical NF-κB pathway Activate Inhibit
Alternative NF-κB pathway Activate No
AP-1 activity Activate Inhibit
JunD transcription Activate Activate
T-cell proliferation Activate Activate
TGF-β signaling Inhibit Activate
Host immune response Enhance Suppress
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ANTISENSE TRANSCRIPT OF RETROVIRUS
There are four kinds of HTLVs have been identiﬁed, and their
oncogenic property is different. HTLV-1 mainly infected CD4+
T cells. However, HTLV-2 tends to target CD8+ T cells, and
induces cancer only in rare cases. Unlike Tax1, Tax2 which encodes
by HTLV-2 does not have PDZ domain-binding motif (PBM).
Since PBM is important for the transforming activity, such dif-
ferences between Tax1 and Tax2 may responsible for the different
pathogenicities of HTLV-1 and HTLV-2 (Hirata et al., 2004). It was
reported that HTLV-2 produced an antisense transcript termed
antisense protein (ASP) of HTLV-2 (APH-2; Figure 3; Halin et al.,
2009). Like the sHBZ gene, APH-2 mRNA is transcribed from the
3′LTR, and spliced and polyadenylated. APH-2 does not contain
bZIP domain but it still could interact with CREB and suppresses
Tax2-dependent LTR activation. In addition, APH-2 did not colo-
calize with the nucleolus, although in non-T and T cells, it did
have nuclear localization. Importantly, APH-2 was correlated with
proviral load, while it does not promote cell proliferation and does
not cause lymphocytosis.
Recent reports showed that HTLV-3 and HTLV-4 produce
a spliced and polyadenylated antisense transcript (Barbeau and
Mesnard, 2011). These two proteins were named as APH-3 and
APH-4, respectively, since both proteins lack consensus bZIP
domain (Figure 3). But, they retained the capacity to inhibit
LTR activation that mediated by their respective Tax proteins.
This study demonstrated a nuclear-restricted pattern for APH-
4 while APH-3 was localized both in the cytoplasm and in
the nucleus.
A naturally occurring antisense RNA was identiﬁed in the cell
lines infected with HIV-1, and encodes an ASP with an appar-
ent molecular mass of 19 kDa (Figure 3; Vanhee-Brossollet et al.,
1995; Clerc et al., 2011). Antibodies against this protein have
been detected in the sera of HIV-positive individuals. However,
it remains to be elucidated the function of this ASP in vivo.
PERSPECTIVES
Intensive studies on the leukemogenesis of ATL since the dis-
covery of HTLV-1 have revealed some molecular mechanisms by
which viral proteins induce viral replication and cellular trans-
formation. However, the precise mechanisms of oncogenesis
by HTLV-1 remain to be clariﬁed. Recent progresses on the
researches of the HBZ gene give new ideas into the mechanisms of
oncogenesis. HBZ is the only viral gene that is expressed in all ATL
FIGURE 3 | Schematic representation of antisense transcripts in HTLV
and HIV proviral genomes. Position of antisense transcript encoded
proteins (APH-2/3/4) in HTLV-2, HTLV-3, and HTLV-4 is similar as HBZ in
HTLV-1. The antisense protein (ASP) encoded by the minus strand of HIV
genome is indicated. The number indicated the total amino acids of each
protein.
cases. Except the HBZ gene, non-sense mutations of other viral
genes are detected before integration of provirus. Importantly,
HBZ maintains the cell survival when Tax is silenced. These data
collectively indicate that HBZ protein has predominate function
on the oncogenesis of HTLV-1. Further studies are needed to
clarify the oncogenic function of HBZ and develop therapy tar-
geted against HBZ based on the growing knowledge of HTLV-1
molecular biology.
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